Ausgabe 5/2023
Inhalt (8 Artikel)
Open Access
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations
Ji Yuan, Rong He, Hassan B. Alkhateeb
Richter Transformation of Chronic Lymphocytic Leukemia—Are We Making Progress?
Hadiyah Y. Audil, Samuel R. Kosydar, Daniel P. Larson, Sameer A. Parikh
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions
Megan Sears-Smith, Thomas G. Knight
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases
Andrea Duminuco, Elena Torre, Giuseppe A. Palumbo, Claire Harrison
Response-Adapted Therapy for Newly Diagnosed Multiple Myeloma
Winnie Z. Y. Teo, Ian Y. E. Ong, Jason W. Y. Tong, Wan Li Ong, Adeline Lin, Fangfang Song, Bee Choo Tai, Melissa Ooi, Cinnie Yentia Seokojo, Yunxin Chen, Chandramouli Nagarajan, Wee Joo Chng, Sanjay de Mel
Multiple Myeloma: Current Clinical Landscape and Compounding Costs
Kelsey Beck, Tyler Sandahl, Sikander Ailawadhi, Nandita Khera, Chelsee Jensen